[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Mary M. Mader<\/i><\/u><\/presenter>. Indiana Biosciences Research Institute, Indianapolis, IN","CSlideId":"","ControlKey":"ab7c9f42-44d9-47cd-add5-4ae05a1505e7","ControlNumber":"322","DisclosureBlock":"&nbsp;<b>&nbsp;M.M. Mader:<\/b>  ; Eli Lilly and Company. ; Eli Lilly and Company. ; Pfizer, Inc.. ; Pfizer, Inc.. ; Relay Therapeutics. ; Relay Therapeutics. ; Revolution Medicines. ; Revolution Medicines. ; Ventus Therapeutics. ; Ventus Therapeutics. ; EQRx. ; EQRx.","End":"4\/8\/2022 5:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"177","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Mary Mader, PhD","PresenterKey":"89b9ce76-5367-47da-ba66-c08410ee7a55","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 5:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Mary M. Mader<\/i><\/u><\/presenter>. Indiana Biosciences Research Institute, Indianapolis, IN","CSlideId":"","ControlKey":"684f1eb6-3322-4fec-82d8-713bbd750130","ControlNumber":"7099","DisclosureBlock":"","End":"4\/8\/2022 5:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"742","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Mary Mader, PhD","PresenterKey":"89b9ce76-5367-47da-ba66-c08410ee7a55","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 5:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Brandon Turunen<\/i><\/u><\/presenter>. GSK, Collegeville, PA","CSlideId":"","ControlKey":"7938d0c5-5e10-42df-878a-9c7e31a073cd","ControlNumber":"7101","DisclosureBlock":"&nbsp;<b>B. Turunen, <\/b> None.","End":"4\/8\/2022 5:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"744","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Brandon Turunen","PresenterKey":"c5624bfd-c220-45d1-855f-63a3965e5278","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chemical biology platforms to drug the undruggable","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 5:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chemical biology platforms to drug the undruggable","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"053ae05e-172c-45d0-9762-a2dfa13f84b4","ControlNumber":"7105","DisclosureBlock":"","End":"4\/8\/2022 5:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"748","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 5:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Christopher Nasveschuk<\/i><\/u><\/presenter>. C4 Therapeutics, Stoneham, MA","CSlideId":"","ControlKey":"254417d2-cfa9-41ab-86a7-9fbfd9268b63","ControlNumber":"7243","DisclosureBlock":"<b>&nbsp;C. Nasveschuk, <\/b> <br><b>C4 Therapeutics<\/b> Employment, Stock, Stock Option, Yes.","End":"4\/8\/2022 5:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"829","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Christopher Nasveschuk, PhD","PresenterKey":"36de9318-08d5-425f-9166-e77ed00b7d9f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Targeted protein degradation: Access to new medicines by drugging challenging targets","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 5:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Targeted protein degradation: Access to new medicines by drugging challenging targets","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"b97f725c-d4c3-4f6d-9528-bcf405ba0e76","ControlNumber":"7111","DisclosureBlock":"","End":"4\/8\/2022 6:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"754","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 5:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Katelyn Billings<\/i><\/u><\/presenter>. Relay Therapeutics, Cambridge, MA","CSlideId":"","ControlKey":"ab2f1c38-ccbc-4dec-8ff8-e9ede498e6fc","ControlNumber":"7100","DisclosureBlock":"<b>&nbsp;K. Billings, <\/b> <br><b>ZebiAI Therapeutics<\/b> Employment, Stock Option, Yes. <br><b>GlaxoSmithKline<\/b> Employment, Yes. <br><b>Vertex Pharmaceuticals<\/b> Other, Spouse employment and stock, No. <br><b>Relay Therapeutics<\/b> Employment, Stock, Stock Option, Yes.","End":"4\/8\/2022 6:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"743","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Katelyn Billings","PresenterKey":"d6ebeef2-68b9-4380-ac86-df8c9c804d84","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Enabling the discovery of new ligands for poorly tractable targets via DNA encoded libraries","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 6:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Enabling the discovery of new ligands for poorly tractable targets via DNA encoded libraries","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"66de7aff-24fe-4fbd-94f0-8f7dfcb7a0fc","ControlNumber":"7112","DisclosureBlock":"","End":"4\/8\/2022 6:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"755","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2022  5:00PM","SessionId":"131","SessionOnDemand":"False","SessionTitle":"Advances in Ligand Discovery Against Poorly Tractable Targets","ShowChatLink":"false","Start":"4\/8\/2022 6:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]